Evidence-based without being evidence-rigid
Or possibly a GLP-1 RA + leptin analog or other appetite modulator together
2023 Exhibit 54: Number of Locations with Specialty Pharmacy Accreditation, by Organization, 2015 to 2025 Exhibit 55: Locations with URAC Specialty Pharmacy Accreditation, 2008 to 2025 Exhibit 56: Prescription Revenues and Market Share from Specialty Pharmaceuticals, by Company, 2025 Exhibit 57: Merger and Acquisition Transactions, Specialty Pharmacy and Infusion Services, 2014 to 2025 Exhibit 58: Pharmacy Locations with Specialty Pharmacy Accreditation, by Corporate Ownership, 2025 Exhibit 59: Specialty Drug Prescription Revenues, by Dispensing Format, 2025 Exhibit 60: Retail Companies with Specialty Pharmacy Businesses, 2025 Exhibit 61: Hospitals and Health System Pharmacy Locations with Specialty Pharmacy Accreditation, 2017 to 2025 Exhibit 62: Hospital and Clinic Share of Oral Oncology Market, 2017 to 2025 Exhibit 63: Hospitals Perceived Barriers to Accessing Specialty Pharmacy Networks, 2020 vs
Strong needle aversion Some patients will simply not start an injection
And formulations using depot technologies produce more reactions than simple solution injections